Evidence map›Paper›PMID 42101925›Full record

SynthesisBriefings in bioinformatics2026

A systematic review of machine learning on clinical MALDI-TOF MS.

Lucía Schmidt-Santiago, Alejandro Guerrero-López, Carlos Sevilla-Salcedo, David Rodríguez-Temporal, Belén Rodríguez-Sánchez, Vanessa Gómez-Verdejo

Abstract readSystematic Review
In one paragraph

Synthesis in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucía Schmidt-SantiagoDepartment of Signal Theory and Communications, Universidad Carlos III de Madrid, Avda. Universidad, 30, E-28911 Leganés, Spain.ORCID 0009-0005-5754-4441
Alejandro Guerrero-LópezInstitute for Medical Microbiology, University of Zurich, Gloriastrasse 30, CH-8006 Zurich, Switzerland.ORCID 0000-0001-8869-3363
Carlos Sevilla-SalcedoDepartment of Signal Theory and Communications, Universidad Carlos III de Madrid, Avda. Universidad, 30, E-28911 Leganés, Spain.ORCID 0000-0002-5507-7537
David Rodríguez-TemporalDepartment of Clinical Microbiology and Infectious Diseases, Gregorio Marañón Health Research Institute, Hospital General Universitario Gregorio Marañón, C. del Dr. Esquerdo 46, E-28007 Madrid, Spain.ORCID 0000-0003-1299-3110
Belén Rodríguez-SánchezDepartment of Clinical Microbiology and Infectious Diseases, Gregorio Marañón Health Research Institute, Hospital General Universitario Gregorio Marañón, C. del Dr. Esquerdo 46, E-28007 Madrid, Spain.ORCID 0000-0002-9625-427X
Vanessa Gómez-VerdejoDepartment of Signal Theory and Communications, Universidad Carlos III de Madrid, Avda. Universidad, 30, E-28911 Leganés, Spain.ORCID 0000-0001-7702-8747

Funding

Comunidad de Madrid's 2025 Cesar Nombela program 2025-T1/COM-36091European Union's Horizon Europe programmeMarie Skłodowska-Curie Actions Postdoctoral Fellowship 101278403Ministry of Science, Innovation and Universities-Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033/FEDERMinistry of Science, Innovation and Universities-Agencia Estatal de Investigación PID2023-146684NB-I00the Community of Madrid TEC-2024/COM-89
6 · The paper itself

Abstract

Bacterial identification, antimicrobial resistance prediction, and strain typification are critical tasks in clinical microbiology, essential for guiding patient treatment and controlling the spread of infectious diseases. While machine learning (ML) has shown immense promise in enhancing Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) applications for these tasks, there is currently no comprehensive review that fully addresses this from a technical ML perspective. To address this gap, we systematically reviewed 115 studies published between 2004 and 2025, focusing on key ML aspects such as data size and balance, preprocessing pipelines, model selection and evaluation, open-source data, and code availability. Our analysis highlights the predominant use of classical ML models like Random Forest and Support Vector Machines, alongside emerging interest in deep learning approaches for handling complex, high-dimensional data. Despite significant progress, challenges such as inconsistent preprocessing workflows, reliance on black-box models, limited external validation, and insufficient open-source resources persist, hindering transparency, reproducibility, and broader adoption. This review offers actionable insights to enhance ML-driven bacterial diagnostics, advocating for standardized methodologies, greater transparency, and improved data accessibility. In addition, we provide guidelines on how to approach ML for MALDI-TOF MS analysis, helping researchers navigate key decisions in model development and evaluation.

Indexed as

BacteriaMachine LearningSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationHumansRandom Forestantimicrobial resistancebacterial identificationbacterial typingdeep learningmachine learningMALDI-TOF MS

Identifiers

PMID42101925
PMCPMC13155116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.